Welcome to the OMA Blog
The Obesity Medicine Association Blog is the leading industry hub for obesity medicine. Find the latest research, expert insights, and practical tips to tackle the multifaceted disease of obesity. Hear from OMA Outreach Committee members, OMA Board members, and more to gain a deeper understanding of the complex factors influencing obesity and explore innovative approaches to prevention, treatment, and long-term management. Join a community of healthcare professionals, researchers, and individuals passionate about combating obesity.
View by Category
OMA Member Story: Raghuveer Vedala
Dr. Raghuveer Vedala always knew he wanted to make a difference in people's lives and his interest in healthcare came from his own experiences with the field. As a child, Dr. Vedala struggled with juvenile epilepsy. While he didn't fully grasp it at the time, he later realized that the support and dedication of his healthcare providers left an undeniable mark on him. Their compassion fueled a desire in young Raghuveer to pursue a career in healthcare.
Obesity Pillars Volume 10
Volume 10 features predictions in obesity medicine, a joint expert review from the OMA and the National Lipid Association , commentary on a weight bias internalization tool for use in pregnancy, and more. Future of Obesity Medicine: Fearless 5-year Predictions for 2029 by OMA Committee Chairs This annual predictions article provides a "time capsule" of thoughts from OMA leaders and members regarding the potential future of obesity medicine in five years. Read Article Evaluating the effectiveness and underlying mechanism of incretin-based treatment for hypothalamic obesity: A narrative review Authors: Dionysios V. Read Article Obesity Pillars ® Journal Obesity Pillars® is an open-access online-only journal published by the Obesity Medicine Association in collaboration with Elsevier.
Rising Obesity Rates in America: A Public Health Crisis
Research has shown that obesity is reported to be a public crisis in the US (1,2,3). Worldwide obesity has tripled since 1975 (18). Obesity is…
Pediatric Research Update | Treatment of Hypothalamic Obesity
This month’s update addresses treatment of hypothalamic obesity. Treatment of Hypothalamic Obesity in People with Hypothalamic Injury: New Drugs are on the Horizon Article Summary Hypothalamic obesity (HO) is a complex disorder resulting from either monogenic cause or injury of the hypothalamus. Read Full Article Article Review The article addresses the complex condition of hypothalamic obesity (HO). Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon.
Obesity Medicine Association Announces the 2024 OMA Award Winners
The Obesity Medicine Association (OMA) announced its 2024 Award Winners at the recent Obesity Medicine 2024 conference in Denver, CO this April. ABOM Candidate of the Year Award Presented to the OMA member who scored the highest on the American Board of Obesity Medicine Certification Examination Recipient: Joseph Brewster, MD The Steelman-Seim Educator Award for Excellence in Academics For excellence in academics Recipient: Sylvia Gonsahn-Bollie, MD, DABOM, FOMA Dr.
Obesity Management Foundations for the Primary Care Clinician
Collaborative course available from the AANP and the OMA.
Pediatric Research Update | Do Mindfulness Interventions Improve Obesity Rates in Children and Adolescents: A Review of the Evidence
Each month, the OMA Pediatric Committee reviews a pediatric-focused obesity research update to help keep you up to date about the latest findings.
New “Supportive Obesity Care” Website for Healthcare Professionals
Our society can be hostile toward people with obesity who commonly face judgment, prejudice, and unfair treatment in their daily lives. This problem extends to the healthcare setting, where patients can face weight bias and stigma from physicians, nurses, psychologists, dietitians, medical students, and even healthcare professionals who specialize in obesity.
Insulin and Weight Gain: Understanding the Connection
Insulin is a commonly used medication to treat patients with both type 1 and type 2 diabetes. Weight gain is a commonly seen side effect. Patients may have questions about insulin and potential weight gain out of concern for their appearance or their health (or both).